PV
GILD icon

Private Vista’s Gilead Sciences GILD Stock Holding History

Private Vista’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,804
Closed -$209K – 133
2020
Q1 		$209K Buy
+2,804
New +$194K 0.08% 126
2019
Q4 		– Sell
-4,785
Closed -$304K – 152
2019
Q3 		$304K Buy
+4,785
New +$313K 0.08% 109

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Private Vista's GILD Position: Q2 2020 in Review

Private Vista sold out of Gilead Sciences (GILD) in Q2 2020, closing a stake of 2,804 shares — an estimated $209K sold.

Private Vista first reported a position in GILD in Q3 2019 and held it in 2 quarters. The position peaked at $304K in Q3 2019. 1,625 funds tracked by Wall St. Rank hold GILD as of Q2 2020.

  • Private Vista reported no remaining Gilead Sciences position as of Q2 2020 after selling out during the quarter.
  • Private Vista sold 2,804 Gilead Sciences shares in Q2 2020, an estimated $209K.
  • Private Vista first reported a position in Gilead Sciences in Q3 2019 and held it in 2 quarters.
  • Private Vista's Gilead Sciences position peaked at $304K in Q3 2019.
  • 1,625 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2020.

Based on Private Vista's 13F filing for Q2 2020, filed 31 Jul 2020.